Regulatory Focus™ > News Articles > India Pharma Reps Protest Corruption, Drug Prices

India Pharma Reps Protest Corruption, Drug Prices

Posted 28 August 2012 | By

Pharmaceutical sales representatives in India went on strike to protest treatment of the reps, increasing drug prices and corporate corruption in their industry, according to PMLive.

The one-day strike was held on 23 August and organized by the Federation of Medical and Sales Representatives Associations of India (FMRAI). The group's newsletter said widespread corruption is creating attacks on the job security of sales reps, including an increase in reps being banned from hospitals and medical institutions.

The PMLive report said FMRAI wants a cap on medicine prices, a code of ethics for sales and marketing practices, and action against pharma corporate corruption.

A GlobalData report said the pharma market in India could reach as high as $54billion by 2020.

Read more 



Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe